The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

Amid promising signs, officials urged caution, noting that the outbreaks vary by clade, response measures, and social ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...

Warren and Duckworth demanded Kennedy make the review public, alongside a similar review the department cited when it cut ...

WASHINGTON >> U.S. Senate Democrats demanded today that Health Secretary Robert F. Kennedy Jr. make public the reviews on ...

Viral claims about Trader Joe's selling HPAI-vaccinated chicken are false. Learn the facts about avian flu vaccines and ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

WASHINGTON, DC – Representative Raja Krishnamoorthi, Ranking Member of the Subcommittee on Healthcare and Financial Services, and other members sent a letter to HHS Secretary Robert F. Kennedy Jr.